Health
Pfizer-BioNTech COVID-19 vaccine effective against variants, study shows – News-Medical.Net
Researchers at NYU Grossman School of Medicine in New York have conducted a study demonstrating the effectiveness of the Pfizer-BioNtech BNT162b2 vaccine against…

Researchers at NYU Grossman School of Medicine in New York have conducted a study demonstrating the effectiveness of the Pfizer-BioNtech BNT162b2 vaccine against recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Nathaniel Landau and colleagues found that sera from vaccinated individuals neutralized recent variants more effectively than sera from convalescent individuals who had been infected before…
-
Business20 hours ago
Macquarie tips 14% upside for this ASX tech stock
-
Noosa News16 hours ago
William Robinson dies aged 89
-
Business20 hours ago
This ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.
-
Noosa News18 hours ago
AFL live updates: Gold Coast vs Essendon – blog, scores and stats